The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

by admin May 29, 2025
May 29, 2025
HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

President Donald Trump’s Department of Health and Human Services (HHS) is terminating awards totaling more than $750 million dollars that were provided to pharmaceutical manufacturer Moderna to help facilitate its production of mRNA-based bird flu vaccines. 

During President Joe Biden’s final week in office, his administration awarded $590 million to Moderna to help speed up its production of mRNA-based vaccines. The $590 million award followed a separate $176 million award Biden gave to Moderna earlier last year for mRNA vaccine technology.

Messenger RNA vaccines are a newer type of vaccine technology, which was utilized by companies like Moderna and Pfizer to develop their COVID-19 vaccines. The vaccine technology was at the center of a lot of criticism amid the coronavirus pandemic for potentially being associated with adverse side effects in some people who took them, such as myocarditis.

Trump administration officials previously hinted at the potential that this funding could be terminated, citing a lack of oversight during the Biden administration pertaining to vaccine production. 

‘After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,’ HHS Communications Director Andrew Nixon said. ‘This is not simply about efficacy — it’s about safety, integrity, and trust. The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public.’

The announcement reflects a larger shift in federal vaccine priorities, after HHS Secretary Robert F. Kennedy Jr. announced earlier this week that COVID-19 vaccines would be removed from the federal government’s list of recommended vaccines for children and pregnant women. 

Meanwhile, a report from Senate Republicans released earlier this month suggested the Biden administration withheld critical safety data and downplayed known risks tied to the mRNA COVID-19 vaccine. In particular, the Senate report focuses on HHS’ awareness of, and response to, cases of myocarditis — a type of heart inflammation — following COVID-19 vaccination.

‘Rather than provide the public and health care providers with immediate and transparent information regarding the risk of myocarditis following mRNA COVID-19 vaccination, the Biden administration waited until late June 2021 to announce changes to the labels for the Moderna and Pfizer COVID-19 vaccines based on the ‘suggested increased risks’ of myocarditis and pericarditis,’ the Senate report states. ‘Even though CDC and FDA officials were well aware of the risk of myocarditis following COVID-19 vaccination, the Biden administration opted to withhold issuing a formal warning to the public for months about the safety concerns, jeopardizing the health of young Americans.’

In response to the Trump administration’s funding termination, Moderna put out a press release acknowledging the move, but also touting the ‘safety profile’ observed amid its work on a new mRNA bird flu vaccine.

‘While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program,’ said Stéphane Bancel, Chief Executive Officer of Moderna. ‘These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats.’

Fox News Digital’s Brooke Singman contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
State Department says it will ‘aggressively’ revoke visas for Chinese students
next post
Musk officially steps down from DOGE after wrapping work streamlining government

Related Posts

Israel’s Minister of Defense cancels visit to Pentagon...

October 9, 2024

Third top Pentagon aide Colin Carroll on administrative...

April 17, 2025

A visibly shaky Walz says the world needs...

October 2, 2024

Jake Sullivan says Netanyahu ‘ready to do a...

December 13, 2024

Netanyahu blasts ‘Iran’s axis of evil’ after Jordan...

September 8, 2024

Melania Trump’s abortion views in new memoir spur...

October 4, 2024

RFK Jr. ‘wrong’ about vaccinations, GOP senator says

January 7, 2025

Top Democrats who pushed 25th Amendment during Trump...

July 4, 2024

Rand Paul suggests replacing Mike Johnson with Elon...

December 20, 2024

Waltz’s Signal chat woes snowball as Trump admin...

April 4, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The Real Drivers of This Market: AI, Semis & Robotics

      July 22, 2025
    • Harvard, Trump battle for billions in federal funds as judge weighs next steps

      July 22, 2025
    • Congressional Republicans face bruising battle to avoid government shutdown

      July 22, 2025
    • Iran seeks China, Russia help to stall UN sanctions ahead of nuclear talks with Europeans

      July 22, 2025
    • Obama-era officials mum on allegations of ‘manufactured’ intelligence launching Trump-Russia probe

      July 22, 2025
    • Hunter Biden special counsel got ‘one resume’ from DOJ to help prosecute president’s son

      July 22, 2025

    Categories

    • Business (1,299)
    • Politics (4,050)
    • Stocks (1,536)
    • Uncategorized (45)
    • World News (1,292)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved